[HTML][HTML] Arginase: a critical regulator of nitric oxide synthesis and vascular function

W Durante, FK Johnson, RA Johnson - Clinical and experimental …, 2007 - ncbi.nlm.nih.gov
ARGINASE: A CRITICAL REGULATOR OF NITRIC OXIDE SYNTHESIS AND VASCULAR
FUNCTION - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Arginase pathway in human endothelial cells in pathophysiological conditions

T Bachetti, L Comini, G Francolini, D Bastianon… - Journal of molecular and …, 2004 - Elsevier
Objective.–Arginase is a nitric oxide synthase-alternative pathway for l-arginine breakdown
leading to biosynthesis of urea and l-ornithine. Arginase pathway is inducible by …

Pathophysiological correlation of arginase-1 in development of type 2 diabetes from obesity in adolescents

S Mazrouei, SF Petry, F Sharifpanah… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Background There is great interest to understand causal pathophysiological correlation
between obesity and diabetes mellitus (DM). Vascular endothelial dysfunction is crucially …

Endothelial arginase II: a novel target for the treatment of atherosclerosis

S Ryoo, G Gupta, A Benjo, HK Lim, A Camara… - Circulation …, 2008 - Am Heart Assoc
Oxidized low-density lipoproteins increase arginase activity and reciprocally decrease
endothelial NO in human aortic endothelial cells. Here, we demonstrate that vascular …

Arginase inhibition alleviates hypertension associated with diabetes: effect on endothelial dependent relaxation and NO production

HM El-Bassossy, R El-Fawal, A Fahmy - Vascular pharmacology, 2012 - Elsevier
Increased arginase activity has been reported in a variety of disease conditions
characterized by vascular dysfunction. In the present study, the potentially protective effect of …

Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications

MS Stem, TW Gardner - Current medicinal chemistry, 2013 - ingentaconnect.com
Diabetic retinopathy (DR), commonly classified as a microvascular complication of diabetes,
is now recognized as a neurovascular complication or sensory neuropathy resulting from …

Tissue‐specific up‐regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus

J Pernow, A Kiss, Y Tratsiakovich… - British journal of …, 2015 - Wiley Online Library
Background and Purpose Emerging evidence suggests a selective up‐regulation of
arginase I in diabetes causing coronary artery disease; however, the mechanisms behind …

Akita spontaneously type 1 diabetic mice exhibit elevated vascular arginase and impaired vascular endothelial and nitrergic function

HA Toque, KP Nunes, L Yao, Z Xu, D Kondrikov, Y Su… - PloS one, 2013 - journals.plos.org
Background Elevated arginase (Arg) activity is reported to be involved in diabetes-induced
vascular endothelial dysfunction. It can reduce L-arginine availability to nitric oxide (NO) …

Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels

DE Berkowitz, R White, D Li, KM Minhas, A Cernetich… - Circulation, 2003 - Am Heart Assoc
Background—Although abnormal l-arginine NO signaling contributes to endothelial
dysfunction in the aging cardiovascular system, the biochemical mechanisms remain …

Arginase 2 deletion reduces neuro-glial injury and improves retinal function in a model of retinopathy of prematurity

SP Narayanan, J Suwanpradid, A Saul, Z Xu, A Still… - PloS one, 2011 - journals.plos.org
Background Retinopathy of prematurity (ROP) is a major cause of vision impairment in low
birth weight infants. While previous work has focused on defining the mechanisms of …